Clinical Significance of MUC1 Mrna Expression in Peripheral Blood and Bone Marrow in Patients with Lung Cancer

牛中喜,郑静晨,朱金茹,李树军,彭碧波,周清华,车国卫

DOI: https://doi.org/10.3969/j.issn.1673-5269.2005.01.005

2005-01-01

Abstract:OBJECTIVE: To detect MUC1 mRNA expression in peripheral blood and bone marrow in patients with non-small cell lung cancer (NSCLC), and to evaluate the clinical significance of MUC1 mRNA expression. METHODS: Nested RT-PCR was used to detect MUC1 mRNA expression in peripheral blood and bone marrow in 31 patients with NSCLC. RESULTS:Positive rates of MUC1 mRNA were 32.3%(10/31) in peripheral blood and 22.6%(7/31) in bone marrow in patients with NSCLC, and highly positive correlation between MUC1 expression in peripheral blood and in bone marrow was found. MUC1 expression was not found in 10 patients with benign pulmonary lesion and 8 normal adults. The MUC1 mRNA expressions in peripheral blood and in bone marrow were closely related to the pathological classification, cell differentiation of cancer and P-TNM stage of the disease,P0.05. CONCLUSIONS:MUC1 mRNA may be a valuable marker to detect DTC in patients with lung cancer. It can also provide important clinical information for the evaluation of prognosis and the selection of appropriate treatment strategies.